Business Standard

'At war time speed': China leads Covid vaccine race with 2 in final stage

Its success in driving down Covid-19 infections makes it harder to conduct large-scale vaccine trials, and so far only a few other countries have agreed to work with it

covid, coronavirus, vaccine, drug, pharma
Premium

China's use of command economy-type tools is so far yielding results.

Reuters Seoul/Singapore
China is forging ahead in the race to develop a vaccine to help control the Covid-19 pandemic, with Sinovac Biotech's experimental vaccine set to become the country's second and the world's third to enter final stage testing later this month.
While a laggard in the global vaccine industry, China, where the new coronavirus is thought to have originated, has brought state, military and private sectors together in a quest to combat a disease that has killed over 500,000 people worldwide.
Many other countries, including the United States, are coordinating closely with the private sector to try to win the vaccine development race,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in